Endocrinology
Conference Coverage
SGLT2 inhibitor use tied to fewer atrial arrhythmias
From the Journals
Does vitamin D benefit only those who are deficient?
The results will “allow clinicians to better weigh the potential benefits of supplementation against its risk,” such as financial cost.
Conference Coverage
Empagliflozin a winner in challenging arena of stabilized acute HF
Early in-hospital initiation of SGLT2 inhibitors “should be considered the new standard of care” in most patients with heart failure regardless of...
Conference Coverage
EMPEROR-Preserved findings confirmed in ‘true’ HFpEF patients
From the Journals
Contact allergens in medical devices: A cause for concern?
Despite the clinical value of medical devices, there is a potential for these products to cause adverse skin reactions in some patients.
From the Journals
Fast foods contain endocrine-disrupting chemicals
“There’s very limited research out there to understand the human health effects” of DEHT in food.
Latest News
New study ‘changes understanding of bone loss after menopause’
The study sheds light on long-term changes in BMD in postmenopausal women and “stresses the importance of high peak bone mass before menopause and...
From the Journals
Nondiabetes hospitalization is wrong time to up diabetes meds
Diabetes treatment intensification after being hospitalized for reasons other than diabetes was linked with a short-term increase in risk of...
From the Journals
Free vitamin D no better at predicting death in men than standard testing
Conference Coverage
What are the cardiorenal differences between type 1 and type 2 diabetes?
Heart failure may be as much, if not more of, a problem in people with type 1 diabetes as type 2 diabetes, researchers suggested.
From the Journals
Bone risk: Is time since menopause a better predictor than age?
The amount of time since a woman’s final menstrual period factors into bone density and fracture risk, in some cases with an even stronger...